On 4/30/24, Medifast Inc. (NYSE: MED) stock suffered a major decline of -22.5%, closing at $27.53. Moreover, exceptionally high trading volume at 405% of normal accompanied the decline. Relative to the market the stock has been extremely weak over the last nine months and has declined -15.6% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, MED is expected to continue to be an important Value Builder.
Medifast has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects complementary signals from PTR’s two proprietary measures of a stock’s attractiveness. Medifast has a slightly negative Appreciation Score of 38 and a very low Power Rating of 1, and the Lowest Value Trend Rating results.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment